Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease-Reference-Cited by-同舟云学术

Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease

Published:2022-10-20 Issue:1 Volume:46 Page:13-21
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clinical Cardiology

Author:

Desai Nihar R.¹,Farbaniec Michael²,Karalis Dean G.³

Affiliation:

1. Yale School of Medicine, Cardiovascular Medicine Section New Haven Connecticut USA

2. Heart and Vascular Institute Penn State University Hershey Pennsylvania USA

3. Department of Cardiology Thomas Jefferson University Philadelphia Pennsylvania USA

Funder

Novartis Pharmaceuticals Corporation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23935

Reference46 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

2. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American college of Cardiology/American heart association task force on clinical practice guidelines;Grundy SM;Circulation,2018

3. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

4. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group

5. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Closing the gap between guidelines and clinical practice for managing dyslipidemia: where are we now?;Expert Review of Cardiovascular Therapy;2024-09

2. Ezetimibe use and mortality after myocardial infarction: A nationwide cohort study;American Journal of Preventive Cardiology;2024-09

3. Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond;American Journal of Preventive Cardiology;2024-09

4. Total Cholesterol Determination Accuracy in Dried Blood Spots;Diagnostics;2024-08-29

5. Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications;American Journal of Cardiovascular Drugs;2024-08-13